Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes
Baylor University Medical Center · Mayo Clinic · +20 more institutions
Abstract
Evidence about the efficacy of laparoscopic resection of rectal cancer is incomplete, particularly for patients with more advanced-stage disease.
To determine whether laparoscopic resection is noninferior to open resection, as determined by gross pathologic and histologic evaluation of the resected proctectomy specimen. DESIGN, SETTING, AND PARTICIPANTS: A multicenter, balanced, noninferiority, randomized trial enrolled patients between October 2008 and September 2013. The trial was conducted by credentialed surgeons from 35 institutions in the United States and Canada. A total of 486 patients with clinical stage II or III rectal cancer within 12 cm of the anal verge were randomized after completion of neoadjuvant therapy to laparoscopic or open resection. INTERVENTIONS: Standard laparoscopic and open approaches were performed by the credentialed surgeons. MAIN OUTCOMES AND MEASURES: The primary outcome assessing efficacy was a composite of circumferential radial margin greater than 1 mm, distal margin without tumor, and completeness of total mesorectal excision. A 6% noninferiority margin was chosen according to clinical relevance estimation.
Citation impact
- FWCI
- 47.04
- Percentile
- 100%
- References
- 20
Authors
25- JWJames W. FleshmanCorresponding
Baylor University Medical Center
- MEMegan E. Branda
Mayo Clinic, Alliance Data (United States)
- DJDaniel J. Sargent
Alliance Data (United States), Mayo Clinic
- AMAnne Marie Boller
Northwestern University
- VGVirgilio George
Indiana University School of Medicine, Indiana University – Purdue University Indianapolis
Topics & keywords
- Medicine
- Resection margin
- Abdominoperineal resection
- Surgery
- Colorectal cancer
- Stage (stratigraphy)
- Laparoscopy
- Randomized controlled trial
- Good health and well-being